MustGrow Biologics Corp
XTSX:MGRO
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.54
1.49
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
|
MustGrow Biologics Corp
XTSX:MGRO
|
37.7m CAD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.7B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.1B EUR |
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
48.8B USD |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280.3B CNY |
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
28.5B USD |
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
22.5B USD |
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
20.6B USD |
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
20.3B USD |
Loading...
|
|
| DK |
|
Genmab A/S
CSE:GMAB
|
128.9B DKK |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
MustGrow Biologics Corp
Glance View
MustGrow Biologics Corp. engages in the development and commercialization of natural biopesticide products from mustard seed. The company is headquartered in Saskatoon, Saskatchewan. The company went IPO on 2019-07-10. The firm is focused on providing natural science-based biological solutions for high value crops, including fruits and vegetables, and other industries. The company has designed and owns a natural solution, which uses the mustard seed's natural defense mechanism to protect plants from pests and diseases. The product, in granule format, is available across all key United states and by Health Canada's Pest Management Regulatory Agency (PMRA) as a biopesticide for high value crops, such as in fruit and vegetables. The company concentrates on a mustard extract biopesticide in liquid format, TerraMG and could be applied through standard drip or spray equipment, improving functionality and performance features. In addition, the Company's mustard-derived extract technologies could have other applications in several different industries from preplant soil treatment, to weed control, to postharvest disease control and food preservation.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for MustGrow Biologics Corp is -81.1%, which is above its 3-year median of -223.6%.
Over the last 2 years, MustGrow Biologics Corp’s Operating Margin has decreased from -17.1% to -81.1%. During this period, it reached a low of -1 285% on Dec 31, 2024 and a high of 14.4% on Sep 30, 2024.